COLUMBIA, Md., July 10 /PRNewswire-FirstCall/ -- Martek Biosciences Corporation (Nasdaq: MATK) announced today that it will conduct a conference call for investors to discuss DHA research recently presented at the International Conference on Alzheimer's Disease. The call will take place July 13, 2009, at approximately 9 a.m. Eastern Time (ET). All interested parties may listen to the call live via webcast by visiting Martek's web site at http://investors.martek.com.
An archived webcast of the conference call will be available on the Martek's website for thirty days. In addition, a recorded playback of the call will be available for one week and can be accessed by calling 800-633-8284 or 402-977-9140 and entering pass code 214 31512.
Martek Biosciences Corporation is a leader in the innovation and development of DHA omega-3 products that promote health and wellness through every stage of life. The Company produces life'sDHA(TM), a sustainable and vegetarian source of DHA omega-3, for use in foods, beverages, infant formula and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com/.
Kyle Stults Investor Relations (410) 740-0081 email@example.com
|SOURCE Martek Biosciences Corporation|
Copyright©2009 PR Newswire.
All rights reserved